Satyadeeptha Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Humnabad, Karnataka, India, established in 1987.
1987 Humnabad, Karnataka, India Active
Last Updated:
Access Report
About Satyadeeptha Pharmaceuticals Limited

Satyadeeptha Pharmaceuticals Limited, a active public limited company, was established on 10 March 1987 in Humnabad, Karnataka, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U85110KA1993PLC013900. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹3.88 Cr.

Formerly known as Gladwin Pharmaceuticals Limited. It upholds a compliant status. Employing 166 professional, Its leadership includes Prasada Rao Kalluri (Director), Surapaneni Janardhana Rao (Whole-Time Director), Surapaneni Sarojinidevi (Whole-Time Director). Past directors included Prasada Rao Kalluri, Srinivasarao Bolla, Nageswara Rao Balusupati. It holds ₹145.63 Cr open charges and ₹52.48 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.101A, 101B, 101P1 & 100P4 Industrial Development Area, Humnabad, Karnataka, 585330.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85110KA1993PLC013900

  • Registration Number

    013900

  • Incorporation Date

    10 March 1987

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹3.88 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 3.88 Cr
  • Company Age 38 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 145.63 Cr
  • Satisfied Charges ₹ 52.48 Cr
Company report

Satyadeeptha Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Satyadeeptha Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Satyadeeptha Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Prasada Rao Kalluri Director 25 Sep 2021 Current
Surapaneni Janardhana Rao Whole-Time Director 24 Feb 2023 Current
Surapaneni Sarojinidevi Whole-Time Director 20 Mar 1999 Current
Sudheer Kumar Aleti Director 30 Sep 2025 Current
Surapaneni Ramakrishna Managing Director 18 Jan 1993 Current
Mandapakala Neelalohita Director 30 Sep 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Nov 2021 Past
Pramod Abcsdd Director 30 Sep 2025 Past
Pramod Abcsdd Director 30 Sep 2025 Past
Pramod Abcsdd Director 06 Aug 2012 Past
Pramod Abcsdd Director 25 Sep 2021 Past
Pramod Abcsdd Director 10 Sep 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Satyadeeptha Pharmaceuticals.

Satyadeeptha Pharmaceuticals Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Satyadeeptha Pharmaceuticals revenue growth over time
Satyadeeptha Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Satyadeeptha Pharmaceuticals?

In 2023, Satyadeeptha Pharmaceuticals had a promoter holding of 95.93% and a public holding of 4.07%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,456,263,000.00

Satisfied Charges

₹524,829,823.73

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 85.58 Cr
  • Canara Bank : 40.05 Cr
  • Others : 20.00 Cr
Latest Charge Details
Date Lender Amount Status
12 May 2025 Others ₹20.00 Cr Open
11 Nov 2022 Hdfc Bank Limited ₹1.50 Cr Open
07 Oct 2022 Hdfc Bank Limited ₹2.26 Cr Open
07 Oct 2022 Hdfc Bank Limited ₹4.52 Cr Open
05 Jan 2022 Canara Bank ₹3.20 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Satyadeeptha Pharmaceuticals?

Satyadeeptha Pharmaceuticals has a workforce of 166 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Satyadeeptha Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Satyadeeptha Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Satyadeeptha Pharmaceuticals
Recent Activity within the Organization
  • Charges

    Progress on A charge registered on 22 Apr 2021 via Charge ID 100437986 with Canara Bank was fully satisfied on 15 Oct 2025. was documented.

  • Annual General Meeting

    Satyadeeptha Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    Progress on Sudheer Kumar Aleti was appointed as a Director was appointed as a Director on 30 Sep 2025 & has been associated with this company since 4 months 19 days . was documented.

  • Director Appointment

    Mandapakala Neelalohita was appointed as a Director was appointed as a Director on 30 Sep 2025 & has been associated with this company since 4 months 19 days . was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 52.00 Cr registered on 01 Mar 2021 with Charge ID 100436435 was modified on 09 Jun 2025. was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101114157 was registered on 12 May 2025. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Satyadeeptha Pharmaceuticals Limited?

The CIN of Satyadeeptha Pharmaceuticals Limited is U85110KA1993PLC013900.

Where is Satyadeeptha Pharmaceuticals Limited headquartered?

Satyadeeptha Pharmaceuticals Limited is headquartered at Plot No.101A, 101B, 101P1 & 100P4 Industrial Development Area, Humnabad, Karnataka, 585330.

When was Satyadeeptha Pharmaceuticals Limited incorporated?

Satyadeeptha Pharmaceuticals Limited was incorporated on 10 March 1987.

Who are the current directors of Satyadeeptha Pharmaceuticals Limited?

The current directors of Satyadeeptha Pharmaceuticals Limited are

What is the primary industry of Satyadeeptha Pharmaceuticals Limited?

The primary industry of Satyadeeptha Pharmaceuticals Limited is Manufacturing.

Is Satyadeeptha Pharmaceuticals Limited a listed company?

Satyadeeptha Pharmaceuticals Limited is unlisted.

What is the capital structure of Satyadeeptha Pharmaceuticals Limited?

The authorized capital of Satyadeeptha Pharmaceuticals Limited is ₹5.00 Cr, and the paid-up capital is ₹3.88 Cr.

What is the compliance status of Satyadeeptha Pharmaceuticals Limited?

The compliance status of Satyadeeptha Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available